- Home
- PRHI vs FLGC Comparison
PRHI vs FLGC Comparison
Compare PRHI & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRHI
- FLGC
- Stock Information
- Founded
- PRHI 2009
- FLGC 2019
- Country
- PRHI United States
- FLGC United States
- Employees
- PRHI N/A
- FLGC N/A
- Industry
- PRHI Property-Casualty Insurers
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- PRHI Finance
- FLGC Health Care
- Exchange
- PRHI Nasdaq
- FLGC Nasdaq
- Market Cap
- PRHI 13.7M
- FLGC 13.5M
- IPO Year
- PRHI N/A
- FLGC 2021
- Fundamental
- Price
- PRHI $1.45
- FLGC $11.63
- Analyst Decision
- PRHI
- FLGC Strong Buy
- Analyst Count
- PRHI 0
- FLGC 1
- Target Price
- PRHI N/A
- FLGC $156.00
- AVG Volume (30 Days)
- PRHI 2.1M
- FLGC 30.6K
- Earning Date
- PRHI 11-12-2025
- FLGC 11-12-2025
- Dividend Yield
- PRHI N/A
- FLGC N/A
- EPS Growth
- PRHI N/A
- FLGC N/A
- EPS
- PRHI 2.45
- FLGC N/A
- Revenue
- PRHI $52,654,000.00
- FLGC $52,373,000.00
- Revenue This Year
- PRHI $25.91
- FLGC N/A
- Revenue Next Year
- PRHI N/A
- FLGC $10.48
- P/E Ratio
- PRHI $0.60
- FLGC N/A
- Revenue Growth
- PRHI N/A
- FLGC N/A
- 52 Week Low
- PRHI $0.42
- FLGC $11.05
- 52 Week High
- PRHI $2.83
- FLGC $82.25
- Technical
- Relative Strength Index (RSI)
- PRHI N/A
- FLGC 31.74
- Support Level
- PRHI N/A
- FLGC $17.80
- Resistance Level
- PRHI N/A
- FLGC $20.45
- Average True Range (ATR)
- PRHI 0.00
- FLGC 1.71
- MACD
- PRHI 0.00
- FLGC -0.80
- Stochastic Oscillator
- PRHI 0.00
- FLGC 6.22
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.